Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;14(1):50-59.
doi: 10.15420/ecr.2018.33.1.

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

Sotirios Tsalamandris  1 , Alexios S Antonopoulos  1 , Evangelos Oikonomou  1 , George-Aggelos Papamikroulis  1 , Georgia Vogiatzi  1 , Spyridon Papaioannou  1 , Spyros Deftereos  1 , Dimitris Tousoulis  1
Affiliations
Review

The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives

Sotirios Tsalamandris et al. Eur Cardiol. 2019 Apr.

Abstract

Diabetes is a complex metabolic disorder affecting the glucose status of the human body. Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical relationship between diabetes and atherosclerotic cardiovascular disease is well established. This makes therapeutic approaches that simultaneously target diabetes and atherosclerotic disease an attractive area for research. The majority of people with diabetes fall into two broad pathogenetic categories, type 1 or type 2 diabetes. The role of obesity, adipose tissue, gut microbiota and pancreatic beta cell function in diabetes are under intensive scrutiny with several clinical trials to have been completed while more are in development. The emerging role of inflammation in both type 1 and type 2 diabetes (T1D and T1D) pathophysiology and associated metabolic disorders, has generated increasing interest in targeting inflammation to improve prevention and control of the disease. After an extensive review of the possible mechanisms that drive the metabolic pattern in T1D and T2D and the inflammatory pathways that are involved, it becomes ever clearer that future research should focus on a model of combined suppression for various inflammatory response pathways.

Keywords: Inflammation; adipose tissue; anti-inflammatory treatment; diabetes; metabolic disorders; obesity.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors have no conflicts of interest to declare.

Figures

Figure 1:
Figure 1:. Inflammatory Mediators in Type 1 Diabetes
Figure 2:
Figure 2:. The Vicious Cycle of Inflammation in Various Target Organs in Type 2 Diabetes
See this image and copyright information in PMC

References

    1. Inzucchi SE. Diagnosis of diabetes. N Engl J Med. 2013;368:193. doi: 10.1056/NEJMc1212738. - DOI - PubMed
    1. Gregg EW, Li Y, Wang J et al. Changes in diabetes-related complications in the United States, 1990-2010. N Engl J Med. 2014;370:1514–23. doi: 10.1056/NEJMoa1310799. - DOI - PubMed
    1. Haffner SM, Lehto S, Rönnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339:229–34. doi: 10.1056/NEJM199807233390404. - DOI - PubMed
    1. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29–36. doi: 10.1016/S0140-6736(06)68967-8. - DOI - PubMed
    1. Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–52. doi: 10.1093/eurheartj/eht142. - DOI - PubMed